Welcome to Penn Vet’s new website; now in the last phase of completion. If you are a member of the Penn Vet community and see an issue, please complete our feedback form.

    Pascale C. Salah, DVM, DrPh II, DACVIM

    Case, A., Brisson, B. K., Durham, A. C., Rosen, S., Monslow, J., Buza, E., Salah, P., Gillem, J., Ruthel, G., Veluvolu, S., Kristiansen, V., Pure, E., Brown, D. C., Sorenmo, K. U., Volk, S. W.Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma PLoS One 12: e0180448, 2017.

    Salah, P. C. Polycythemia vera Clinical Veterinary Advisor. Dogs and Cats : , 2015.

    Krick, E. L., Cohen, R. B., Gregor, T. P., Salah, P. C., Sorenmo, K. U. Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats J Vet Intern Med 27: 134-40, 2013.

    Eshar, D., Wyre, N. R., Griessmayr, P., Durham, A., Hoots, E. Diagnosis and treatment of myelo-osteolytic plasmablastic lymphoma of the femur in a domestic ferret J Am Vet Med Assoc 237: 407-14, 2010.

    Griessmayr, P. C., Payne, S. E., Winter, J. E., Barber, L. G., Shofer, F. S. Dacarbazine as single-agent therapy for relapsed lymphoma in dogs J Vet Intern Med 23: 1227-31, 2009.

    Winter, J. L., Barber, L. G., Freeman, L., Griessmayr, P. C., Milbury, P. E., Blumberg, J. B.Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma J Vet Intern Med 23: 311-6, 2009.

    Griessmayr, P. C., Gauthier, M., Barber, L. G., Cotter, S. M. Mushroom-derived maitake PETfraction as single agent for the treatment of lymphoma in dogs J Vet Intern Med 21: 1409-12, 2007.

    Hartmann, K., Griessmayr, P., Schulz, B., Greene, C. E., Vidyashankar, A. N., Jarrett, O., Egberink, H. F. Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection J Feline Med Surg 9: 439-45, 2007.

    The treatment of canine lymphoma and the use and efficacy of rescue protocols. 

    Actively involved in on-going immunotherapy clinical trials for dogs with B-cell lymphoma (CAR Tcell), canine hemangiosarcoma, and canine osteosarcoma.

    Clinical Specialties:

    Lymphoma, Hemangiosarcoma, CAR-T Cell, Immunotherapy, Osteosarcoma, Medical Oncology

    Hospital & Services:

    Education:

    MS/DrPh II (Veterinary Medicine) Ludwig-Maximilians University, 2002; DVM (Veterinary Medicine) University of Hannover School of Veterinary Medicine, 1999

    Board Certification:

    Diplomate, American College of Internal Medicine (Oncology)

    Contact:

    University of Pennsylvania

    School of Veterinary Medicine

    3800 Spruce Street

    Philadelphia, PA 19104